• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】36959

【品名】5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine

【CA登记号】

【 分 子 式 】C10H20FN3OSi2

【 分 子 量 】273.4578232

【元素组成】C 43.92% H 7.37% F 6.95% N 15.37% O 5.85% Si 20.54%

与该中间体有关的原料药合成路线共 11 条

合成路线1

该中间体在本合成路线中的序号:(XV)

The reaction of 1,4-dithiane-2,5-diol (XII) with 2-(benzoyloxy)acetaldehyde (XIII) in hot pyridine gives 5-acetoxy-2-(benzoyloxymethyl)-1,3-oxathiolane (XIV), which is condensed with fully silylated cytosine (XV) (obtained by silylation of cytosine (XVI) with HMDS) by means of TBDMS-OTf, yielding, after acetylation with Ac2O, a mixture of the desired racemic-cis substituted fluorocytosine (XVII) along with its racemic trans isomer, which are separated by flash chromatography. The deacylation of (XVII) with ammonia in methanol gives the racemic cis-2-(hydroxymethyl)-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (XVIII), which is phosphorylated with POCl3 and water in trimethyl phosphate yielding the racemic phosphate (XIX). The enantioselective dephosphorylation of (XIX) with 5'-nucleotidase (Sigma), affords a mixture of the (+)-(cis)-dephosphorylated compound (XXI) and unreacted (-)-(cis)-compound (XX) that are separated by column chromatography. Finally, (XX) is dephosphorylated by means of alkaline phosphatase (Sigma) to afford the target compound.

1 Dionne, G. (BioChem Pharma Inc.); 1,3-Oxathiolane nucleoside analogues. EP 0526253; JP 1995500317; US 5538975; WO 9303027 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XII) 36958 1,4-dithiane-2,5-diol 40018-26-6 C4H8O2S2 详情 详情
(XIII) 15605 2-oxoethyl benzoate C9H8O3 详情 详情
(XIV) 36964 [5-(acetoxy)-1,3-oxathiolan-2-yl]methyl benzoate C13H14O5S 详情 详情
(XV) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(XVI) 16747 4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine 2022-85-7 C4H4FN3O 详情 详情
(XVII) 36960 [(2R,5S)-5-[4-(acetamido)-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl benzoate C17H16FN3O5S 详情 详情
(XVIII) 36961 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone C8H10FN3O3S 详情 详情
(XIX) 64685 (rac)-({(2R*,5S*)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl}methyl dihydrogen phosphate) C8H11FN3O6PS 详情 详情
(XX) 36962 [(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl dihydrogen phosphate C8H11FN3O6PS 详情 详情
(XXI) 36963 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone C8H10FN3O3S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XV)

The acylation of 2-butene-1,4-diol (XXII) with butyryl chloride and DMAP in pyridine gives the dibutyrate (XXIII), which is ozonolyzed with O3 in dichloromethane yielding the aldehyde (XXIV). The cyclization of (XXIV) with mercaptoacetic acid (XXV) in refluxing toluene affords 2-(butyryloxymethyl)-1,3-oxathiolane-5-one (XXVI), which is reduced with lithium tri-tert-butoxyaluminum hydride and acetylated with acetic anhydride in THF to give 5-acetoxy-2-(butyryloxymethyl)-1,3-oxathiolane (XXVII). The condensation of (XXVII) with disilylated 5-fluorocytosine (XV) (obtained from cytosine (XVI) as described) by means of SnCl4 in dichloromethane yields the racemic butyryl nucleoside rac-(cis)-(XXVIII). The biological resolution of this racemic mixture has been performed by digestion with the enzyme pig liver esterase (PLE-A) providing a mixture of unreacted (-)-(cis)-(2R,5S)-(XXVIII) butyrate and hydrolyzed (+)-(cis)-(2S,5R)-(XXIX) that are separated by fractional extraction. The desired (-)-(cis)-(2R,5S)-enantiomer is finally hydrolyzed to the target compound with NaOMe in methanol. The biological resolution of rac-(cis)-(XXVIII) can also be performed with the enzyme Amano PS-800 yielding a mixture of unreacted (+)-(cis)-(2S,5R)-(XXVIII) butyrate and the desired (-)-(cis)-(2R,5S) target nuceloside that are separated by fractional extraction.

1 Liotta, D.C.; Schinazi, R.F.; Choi, W.-B. (Emory University); Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane. EP 0984013; JP 1994508605; JP 1998147586; WO 9214743 .
2 Hoong, L.K.; et al.; Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2', 3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compounds. J Org Chem 1992, 57, 21, 5563.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(rac)-(XXVIII) 36970 (rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(+)-(XXVIII) 36971 [(2S,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(-)-cis-(XXVIII) 36972 (-)-cis-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(XV) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(XVI) 16747 4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine 2022-85-7 C4H4FN3O 详情 详情
(XXII) 36965 (Z)-2-butene-1,4-diol 6117-80-2 C4H8O2 详情 详情
(XXIII) 36966 (Z)-4-(butyryloxy)-2-butenyl butyrate C12H20O4 详情 详情
(XXIV) 36967 2-oxoethyl butyrate C6H10O3 详情 详情
(XXV) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(XXVI) 36968 (5-oxo-1,3-oxathiolan-2-yl)methyl butyrate C8H12O4S 详情 详情
(XXVII) 36969 [5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate C10H16O5S 详情 详情
(XXIX) 36963 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone C8H10FN3O3S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(IX)

A new process for the preparation of emtricitabine has been described: The esterification of 2-butene-1,4-diol (I) with butyryl chloride and DMAP in pyridine gives the diester (II), which by ozonolysis with O3 in methanol provides the hemiacetal (III). Cyclization of (III) with 2-mercaptoacetic acid in refluxing toluene affords racemic 2-(butyryloxymethyl)-1,3-oxathiolan-5-one (V), which is submitted to optical resolution to afford the (R)-enantiomer (VI). The reduction of (VI) with Li(t-BuO)3AlH, followed by acetylation with acetic anhydride gives 5-(acetoxy)-2(R)-(butyryloxy)-1,3-oxathiolane (VII), which by treatment with HCl in dichloroethane is converted into 2(R)-(butyryloxy)-5-chloro-1,3-oxathiolane (VIII). Condensation of (VIII) with 5-fluoro-bis(trimethylsilyl)cytosine (IX) ­ obtained by silylation of cytosine (X) with HMDS ­ by means of NaHCO3 in dichloroethane gives a diastereomeric mixture of the butyrate nucleosides (XI), which is hydrolyzed with butylamine in methanol yielding the corresponding diastereomeric mixture of the (2R,5S)-isomer, emtricitabine, and the (2R,5R)-isomer (XII). This mixture is separated by crystallization of the corresponding hydrochlorides obtained by treatment with HCl in methanol/dioxane.

1 Almond, M.; Painter, G.R.; Liotta, D.C.; Cleary, D.; Soria, J. (Emory University; Triangle Pharmaceuticals, Inc.); Method of manufacture of 1,3-oxathiolane nucleosides. WO 0009494 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36965 (Z)-2-butene-1,4-diol 6117-80-2 C4H8O2 详情 详情
(II) 36966 (Z)-4-(butyryloxy)-2-butenyl butyrate C12H20O4 详情 详情
(III) 39681 2-hydroxy-2-methoxyethyl butyrate C7H14O4 详情 详情
(IV) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(V) 36968 (5-oxo-1,3-oxathiolan-2-yl)methyl butyrate C8H12O4S 详情 详情
(VI) 39682 [(2R)-5-oxo-1,3-oxathiolan-2-yl]methyl butyrate C8H12O4S 详情 详情
(VII) 39683 [(2R)-5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate C10H16O5S 详情 详情
(VIII) 39685 [(2R)-5-chloro-1,3-oxathiolan-2-yl]methyl butyrate C8H13ClO3S 详情 详情
(IX) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(X) 16747 4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine 2022-85-7 C4H4FN3O 详情 详情
(XI) 36970 (rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate C12H16FN3O4S 详情 详情
(XII) 36984 benzyl 6-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate C18H17NO3 详情 详情

合成路线4

该中间体在本合成路线中的序号:(X)

The reaction of D-glutamic acid (I) with NaNO2 and HCl gives the lactone carboxylic acid (II), which is esterified with EtOH and Ts-OH to yield the ester (III), reduced with NaBH4 in ethanol and silylated with Tbdps-Cl and imidazole to afford the protected chiral lactone (IV). The selenation of lactone (IV) with N-(phenylseleno)phthalimide (V) by means of LiHMDS and Tms-Cl in THF gives a mixture of diastereomers with a higher ratio (3:1) of the desired isomer (VI). (The unwanted isomer (VII) can be isomerized by reaction with DBU in THF.) The reduction of the lactone (VI) with DIBAL in toluene affords the lactol (VIII), which is treated with Ac2O and TEA to provide the acetoxy compound (IX). The condensation of (IX) with 5-fluoro-N,O-bis(trimethylsilyl)cytosine (X) by means of Tms-OTf in dichloromethane gives the selenated cytosine derivative (XI), which is treated with H2O2 in THF/pyridine to yield the unsaturated silylated precursor (XII). Finally, this compound is desilylated with HF and TEA in THF to afford the target cytosine derivative.

1 Bayes, M.; Sorbera, L.A.; Castaner, J.; ACH-126443. Drugs Fut 2002, 27, 12, 1131.
2 Chen, S.-H.; et al.; Stereoselective syntheses of beta-L-FD4C and beta-L-FddC. J Org Chem 1997, 62, 11, 3449.
3 Chen, S.-H.; Xiuyan, L. (Vion Pharmaceuticals, Inc.); Processes for high-yield diastereoselective synthesis of dideoxynucleosides. WO 9747635 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54708 (R)-(-)-Glutamic acid; (R)-2-Aminoglutaric acid; D-(+)-Glutamic acid; D-2-Aminoglutaric acid; D-glutamic acid 6893-26-1 C5H9NO4 详情 详情
(II) 12006 (R)-(-)-5-Oxo-2-tetrahydrofurancarboxylic acid; (2S)-5-oxotetrahydro-2-furancarboxylic acid 53558-93-3 C5H6O4 详情 详情
(III) 12007 ethyl (2S)-5-oxotetrahydro-2-furancarboxylate; (S)-(+)-gamma-Ethoxycarbonyl-gamma-butyrolactone 55094-96-7 C7H10O4 详情 详情
(IV) 56922 (5R)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)dihydro-2(3H)-furanone C21H26O3Si 详情 详情
(V) 54701 N-(Phenylseleno)phthalimide 71098-88-9 C14H9NO2Se 详情 详情
(VI) 54702 (4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)dihydro-2(3H)-furanone C27H30O3SeSi 详情 详情
(VII) 54703 (4S,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)dihydro-2(3H)-furanone C27H30O3SeSi 详情 详情
(VIII) 54704 (4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)tetrahydro-2-furanol C27H32O3SeSi 详情 详情
(IX) 54705 (4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)tetrahydro-2-furanyl acetate C29H34O4SeSi 详情 详情
(X) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(XI) 54706 4-amino-1-[(2S,4R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-4-(phenylselanyl)tetrahydro-2-furanyl]-5-fluoro-2(1H)-pyrimidinone C31H34FN3O3SeSi 详情 详情
(XII) 54707 4-amino-1-[(2S,5R)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-2,5-dihydro-2-furanyl]-5-fluoro-2(1H)-pyrimidinone C25H28FN3O3Si 详情 详情

合成路线5

该中间体在本合成路线中的序号:(V)

The acylation of 2,3-O-isopropylidene-alpha-D-xylofuranose (I) with benzoyl chloride and pyridine gives the dibenzoyl ester (II), which is deprotected by means of H2SO4/HOAc in hot THF to yield 3,5-di-O-benzoyl-alpha-D-xylofuranose (III). The reaction of (III) with PPh3, I2 and imidazole in dichloromethane affords the glycal (IV), which is used in the glycosylation of the N,O-disilylated 5-fluorocytosine (V) by means of NIS in dichloromethane to provide the 2'-alpha-iodonucleoside (VI). The treatment of (VI) with Zn in EtOH/ethyl acetate (HOAc is used as catalyst) gives the unsaturated nucleoside (VII), which is finally debenzoylated by means of butylamine in THF.

1 Chen, S.-H.; Lin, S.; King, I.; Spinka, T.; Dutschman, G.E.; Gullen, E.A.; Cheng, Y.-C.; Doyle, T.W.; Synthesis and comparative evaluation of two antiviral agents: beta-L-Fd4C and beta-D-Fd4C. Bioorg Med Chem Lett 1998, 8, 22, 3245.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 41907 (3aR,5R,6S,6aR)-5-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol 20031-21-4 C8H14O5 详情 详情
(II) 56701 [(3aR,5R,6S,6aR)-6-(benzoyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate C22H22O7 详情 详情
(III) 56702 [(2R,3R,4R,5S)-3-(benzoyloxy)-4,5-dihydroxytetrahydro-2-furanyl]methyl benzoate C19H18O7 详情 详情
(IV) 56703 [(2R,3R)-3-(benzoyloxy)-2,3-dihydro-2-furanyl]methyl benzoate C19H16O5 详情 详情
(V) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(VI) 56704 [(2R,3S,4R,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-3-(benzoyloxy)-4-iodotetrahydro-2-furanyl]methyl benzoate C23H19FIN3O6 详情 详情
(VII) 56705 {(2S,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-2,5-dihydro-2-furanyl}methyl benzoate C16H14FN3O4 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

The condensation of the known acetate (I) with N,O-disylilated cytosine (II) by means of Tms-OTf or SnCl4 gives the selenium containing nucleoside (III), which is submitted to an oxidative elimination reaction by means of H2O2 and pyridine in dichloromethane to yield the unsaturated nucleoside (IV). Finally, this compound is desilylated by means of TBAF in THF.

1 Shi, J.; et al.; Synthesis and biological evaluation of 2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine (D4FC) analogues: Discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase. J Med Chem 1999, 42, 5, 859.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12217 (3R,5S)-5-([[tert-butyl(diphenyl)silyl]oxy]methyl)-3-(phenylselanyl)tetrahydro-2-furanyl acetate C29H34O4SeSi 详情 详情
(II) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(III) 56706 1-[(2R,3R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-3-(phenylselanyl)tetrahydro-2-furanyl]-5-fluoro-4-[(trimethylsilyl)amino]-2(1H)-pyrimidinone C34H42FN3O3SeSi2 详情 详情
(IV) 56707 1-[(2R,5S)-5-({[tert-butyl(diphenyl)silyl]oxy}methyl)-2,5-dihydro-2-furanyl]-5-fluoro-4-[(trimethylsilyl)amino]-2(1H)-pyrimidinone C28H36FN3O3Si2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

The silylated 5-fluorocytosine (I) is coupled with D-ribofuranose tetraacetate (II) in the presence of SnCl4 in acetonitrile to afford the triacetyl 5-fluorocytidine (III). Acylation of (III) with allyl chloroformate (IV) yields carbamate (V). Then, methanolysis of the acetate ester groups of (V) provides 5-fluoro-N-(allyloxycarbonyl)cytidine (VI). Finally, selective oxidation of the primary alcohol group of (VI) with oxygen and PtO2 gives the target carboxylic acid

1 Kim, K.-H.; Kim, J.-Y; Lee, K-H; Noh, M.-J.; Kim, Y.-C.; Park, H.-J.; Synthesis and biological activity of the new 5-fluorocytosine derivatives, 5'-deoxy-N-alkyloxycarbonyl-5-fluorocytosine-5'-carboxylic acid. Bioorg Med Chem Lett 2002, 12, 3, 483.
2 Lee, K.-H.; Kim, J.-Y.; Kim, Y.-C.; Kim, K.-H.; Park, H.-J.; Noh, M.-J.; Park, Y.-S.; Cho, S.-M. (Kolon Industries, Inc.); 5'-Deoxy-N-(substd. oxycarbonyl)-5-fluorocytosine and derivs. thereof, method of preparing same, and anticancer compsn. comprising same as active ingredients. WO 0211668 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(II) 33835 (2R,3R,4R,5S)-4,5-bis(acetoxy)-2-[(acetoxy)methyl]tetrahydro-3-furanyl acetate 13035-61-5 C13H18O9 详情 详情
(III) 60387 (2R,3R,4R,5R)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]tetrahydro-3-furanyl acetate C15H18FN3O8 详情 详情
(IV) 38115 3-[(chlorocarbonyl)oxy]-1-propene 2937-50-0 C4H5ClO2 详情 详情
(V) 60388 (2R,3R,4R,5R)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-[4-{[(allyloxy)carbonyl]amino}-5-fluoro-2-oxo-1(2H)-pyrimidinyl]tetrahydro-3-furanyl acetate C19H22FN3O10 详情 详情
(VI) 60389 allyl 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-fluoro-2-oxo-1,2-dihydro-4-pyrimidinylcarbamate C13H16FN3O7 详情 详情

合成路线8

该中间体在本合成路线中的序号:(IX)

 

1 Mansour T,Jin H.et al.1997.Processes for the diastereoselective synthesisof nucleoside analogues. US 5696254
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36958 1,4-dithiane-2,5-diol 40018-26-6 C4H8O2S2 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 66301 (2S,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylic acid   C4H6O4S 详情 详情
(IV) 66302 (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylic acid 147027-04-1 C4H6O4S 详情 详情
(V) 15620 (2R,5R)-5-(acetoxy)-1,3-oxathiolane-2-carboxylic acid 147027-05-2 C6H8O5S 详情 详情
(VI) 66303 (2R,5S)-2-isopropyl-5-methylcyclohexanol   C10H20O 详情 详情
(VII) 55067 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate C16H26O5S 详情 详情
(VIII) 66304     C16H26O5S 详情 详情
(IX) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(X) 66305 (2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate   C18H26FN3O4S 详情 详情

合成路线9

该中间体在本合成路线中的序号:(VIII)

 

1 Liotta DC, Schinazi RF, et al.1993. The preparation of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds as anti-HIV nucleosides. US 5210085
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 12234 2-Propen-1-ol; Allyl alcohol 107-18-6 C3H6O 详情 详情
(II) 66313 tert-Butylchlorodiphenylsilane;tert-Butyldiphenylchlorosilane;tert-Butyldiphenylsilyl chloride 58479-61-1 C16H19ClSi 详情 详情
(III) 66314 (allyloxy)(tert-butyl)diphenylsilane   C19H24OSi 详情 详情
(IV) 44475 2-[[tert-butyl(diphenyl)silyl]oxy]acetaldehyde C18H22O2Si 详情 详情
(V) 18524 2-sulfanylacetic acid 68-11-1 C2H4O2S 详情 详情
(VI) 66315 2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-one   C20H24O3SSi 详情 详情
(VII) 55072 (2R)-2-({[tert-butyl(diphenyl)silyl]oxy}methyl)-1,3-oxathiolan-4-yl acetate C22H28O4SSi 详情 详情
(VIII) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(IX) 66316 4-amino-1-((2S,5R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-yl)-5-fluoropyrimidin-2(1H)-one   C24H28FN3O3SSi 详情 详情

合成路线10

该中间体在本合成路线中的序号:(VIII)

 

1 Ren D.2005.Inclustrial scale preparation of emtricitabine.发明专利申请公开说明书,CN 1563002
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(I) 36958 1,4-dithiane-2,5-diol 40018-26-6 C4H8O2S2 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(VI) 66303 (2R,5S)-2-isopropyl-5-methylcyclohexanol   C10H20O 详情 详情
(X) 66305 (2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate   C18H26FN3O4S 详情 详情
(XI) 66306 (2R,5S)-2-isopropyl-5-methylcyclohexyl 2-oxoacetate   C12H20O3 详情 详情
(XII) 66308 (5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate   C14H24O4S 详情 详情
(XIII) 66307 (5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate   C16H26O5S 详情 详情

合成路线11

该中间体在本合成路线中的序号:(VIII)

 

1 Richhariya S.Singh K, et aL 2007.Process for the preparation of crystalline l-menthyl (ZR.5S)-5-( 4-amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)[1,3]oxathiolanr2-carboxylate. W0 2007077505
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(X) 66305 (2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate   C18H26FN3O4S 详情 详情
(XII) 66308 (5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate   C14H24O4S 详情 详情
(XIV) 66309 (5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-chloro-1,3-oxathiolane-2-carboxylate   C14H23ClO3S 详情 详情
Extended Information